erythromycin-A
Test Ligands Values Explained
- Test Ligand ID - A unique identifier for the test ligand
- Ligand Name - Name of the test ligand
| Test Ligand ID | 6110 |
|---|---|
| Ligand Name | erythromycin-A |
| PubMed Compound Id | 12560 |
| Structure | |
| Molecular Formula | C37H67NO13 |
| Molecular Weight | 733.9 |
| SMILES | CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O |
| Synonyms | erythromycin 114-07-8 Erythromycin A E-Mycin Abomacetin Erythromycinum Emgel Erymax Ilotycin Eritromicina Erythromycine Robimycin Eryderm Erythro-Statin Erythromycin base E-Glades Ery-Tab Erycette Erygel Sansac E-Base Erythra-Derm Akne-Mycin ERYC Stiemycin R-P Mycin Eryc Sprinkles E-Solve 2 Erythromast 36 T-Stat Torlamicina C-Solve-2 Erythrogran Eryc 125 erythromycin-A Erythroguent Dotycin Oftalmolosa Cusi Eritromicina Staticin Retcin DTXSID4022991 CHEBI:42355 J01FA01 NSC-55929 PCE (ERYTHROMYCIN) 63937KV33D DTXCID102991 NSC55929 (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione 7540-22-9 Kerymax Spotex Erymax sprinkle Aknemycin plus TStat Eryacne 2 Eryacne 4 Gallimycin-36 T Stat (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl)oxy-14-ethyl-7,12,13-trihydroxy-4-((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-((2S,3R,4S,6R)-4-dimethylamino-3-hydroxy-6-methyloxan-2-yl)oxy-14-ethyl-7,12,13-trihydroxy-4-((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dione (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-dimethylamino-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dione Erythro 200 Lactate, Erythromycin Rommix 250 ec Rommix 500 ec Phosphate, Erythromycin RefChem:6427 Erythro-100 Injection API E.M. Erythromycin Erythromycin Base Filmtab GlyTouCan:G42935TE Erythro-36, Erythro-Dry API E.M ERYTHROMYCIN CHEBI:48923 erythromycin topical solution 2% (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy)-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dione G42935TE Gallimycin Injection, Gallimycin-100 (2R,3S,4S,5R,6R,8R,10R,11R,12S,13R)-5-(3,4,6-Trideoxy-3-dimethylamino-beta-D-xylo-hexopyranosyloxy)-3-(2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyloxy)-6,11,12-trihydroxy-2,4,6,8,10,12-hexamethyl-9-oxopentadecan-13-olide 204-040-1 616-217-4 3''-O-Demethylerythromycin RP-Mycin Erythrocin Eryacne MFCD00084654 Pantomicina A/T/S erythro Ermycin Erycen Aknin Theramycin Z Ak-Mycin Benzamycin Emycin Erytab Inderm CHEMBL532 Dumotrycin Mephamycin Wemid (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione Erythromycin C-13 Endoeritrin Eritomicina Erythroderm Erytrociclin Pharyngocin Proterytrin Acneryne Acnesol Aknemycin C37H67NO13 Derimer Deripil Erisone Eryacnen Erydermer Eryhexal Erysafe Iloticina Latotryd Lederpax Mercina Oftamolets Pantoderm Pantodrin Romycin Stiemicyn Tiprocin Emuvin Erecin Erymed Erytop AustriaS Eros Ery-maxin Erythro-Teva Sans-acne Erimycin-T Ery-Diolan Inderm Gel Del-Mycin Aknederm Ery Gel Udima Ery Gel Emu-Ve 8HPH7ND0LN Skid Gel E (3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)-4-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)oxacyclotetradecane-2,10-dione [3R-(3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)]-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy]oxacyclotetradecane-2,10-dione Akne Cordes Losung ERY Ilosone (estolate) Ilotycin T.S. E-Mycin (base) Ery-Tab (base) Emu-V Ery-B E-Base (base) ERYC (base) N-Methylerythromycin A PCE Dispertab (base) Eryc-125 Eryc-250 Eritromicina [INN-Spanish] Erythromycine [INN-French] Erythromycinum [INN-Latin] Erythromycin, labeled with carbon-13 Staticin (TN) (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione Akne-mycin (TN) Erygel (TN) Eryc (TN) T-stat (TN) Pce (TN) SR-05000001618 Sentry AQ mardel maracyn Erythromycin & VRC3375 erthromycin CCRIS 9078 82343-12-2 UNII-63937KV33D HSDB 3074 NCGC00094670-01 Erythromycin [USP:INN:BAN:JAN] (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione CAS-114-07-8 Prestwick_205 EINECS 204-040-1 NSC 55929 215031-94-0 Spectrum_000115 Spectrum_000659 AI3-50138 EM-A Prestwick3_000151 Spectrum2_000759 Spectrum2_001263 Spectrum4_000538 Spectrum5_001596 UNII-8HPH7ND0LN ERYTHROMYCIN [MI] E0751 Erythromycin A, B + C ERYTHROMYCIN [INN] ERYTHROMYCIN [JAN] EC 204-040-1 ERYTHROMYCIN [HSDB] SCHEMBL2601 ERYTHROMYCIN [VANDF] BSPBio_000282 BSPBio_002480 ERYTHROMYCIN [MART.] KBioGR_001175 KBioSS_000555 KBioSS_001139 MLS001066618 BIDD:GT0017 DivK1c_000294 DivK1c_000397 DivK1c_000702 ERYTHROMYCIN [USP-RS] ERYTHROMYCIN [WHO-DD] ERYTHROMYCIN [WHO-IP] SPECTRUM1500280 SPBio_000778 SPBio_001226 E-Base;E-Mycin;Erytromycin A Erythromycin (mixture A,B,C) BPBio1_000312 GTPL1456 orb1309999 Erythromycin (JP18/USP/INN) HMS500O16 KBio1_000294 KBio1_000397 KBio1_000702 KBio2_000555 KBio2_001139 KBio2_003123 KBio2_003707 KBio2_005691 KBio2_006275 ERYTHROMYCIN [GREEN BOOK] MSK7801 NINDS_000294 NINDS_000397 NINDS_000702 ERYTHROMYCIN [ORANGE BOOK] HMS1920M04 HMS2091D05 HMS2095O04 HMS3712O04 Pharmakon1600-01500280 ERYTHROMYCIN [EP MONOGRAPH] HY-B0220 RKL10096 ERYTHROMYCIN [USP MONOGRAPH] Tox21_111311 Tox21_111869 Tox21_300515 BDBM50344942 CCG-38992 LMPK04000006 MSK7801-100A MSK7801-100M NSC756759 ERYTHROMYCINUM [WHO-IP LATIN] AKOS015895249 MSK7801-1000A MSK7801-1000M AE22796 DB00199 NSC-756759 BENZAMYCIN COMPONENT ERYTHROMYCIN IDI1_000294 IDI1_000397 IDI1_000702 SMP1_000119 NCGC00179619-01 NCGC00179619-02 NCGC00179619-03 NCGC00254234-01 AC-12744 AC-12901 SMR000544946 SY070227 Erythromycin, potency: >=850 mug per mg Erythromycin, tested according to Ph.Eur. SBI-0051368.P003 Erythromycin, N-demethyl-N-(methyl-11C)- Erythromycin 1000 microg/mL in Acetonitrile Erythromycin Solution in Methanol, 100ug/mL NS00000203 Erythromycin Solution in Methanol, 1000ug/mL Erythromycin, meets USP testing specifications C01912 D00140 AB00051981_09 AB00051981_10 Erythromycin Solution in Acetonitrile, 100ug/mL Erythromycin, Biotechnology Performance Certified 114E078 Erythromycin estolate impurity, free erythromycin- Erythromycin Solution in Acetonitrile, 1000ug/mL Q213511 SR-01000799155 Erythromycin, BioReagent, suitable for cell culture SR-01000799155-2 SR-05000001618-1 SR-05000001618-2 BRD-K63550407-001-12-7 BRD-K63550407-001-13-5 BRD-K63550407-028-03-9 BRD-K63550407-028-04-7 Z2587996953 Erythromycin A, European Pharmacopoeia (EP) Reference Standard Erythromycin, United States Pharmacopeia (USP) Reference Standard ERYTHROMYCIN ESTOLATE IMPURITY, FREE ERYTHROMYCIN [EP IMPURITY] ERYTHROMYCIN ESTOLATE IMPURITY, FREE ERYTHROMYCIN- [USP IMPURITY] Erythromycin, for microbiological assay, European Pharmacopoeia (EP) Reference Standard Erythromycin, Pharmaceutical Secondary Standard; Certified Reference Material (3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-.alpha.-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3- (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-(2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyloxy)-14-ethyl-7,12,13-trihydroxy-6-[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyloxy]-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (non-preferred name) [3R-(3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)]-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-|A-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-|A-D-xylo-hexopyranosyl]oxy]oxacyclotetradecane-2,10-dione |
| Created At | Jan 13, 2025 2:47 pm |
| Updated At | Jan 13, 2025 2:47 pm |